Skip to main content
OpenTrials

Clinical trial condition

Sphingolipidoses

Explore clinical trials studying Sphingolipidoses. Study availability and eligibility vary by location and protocol.

389 public trials 81 recruiting studies
Refine in advanced search Browse all conditions

Sphingolipidoses trial results

Completed

A Safety and Efficacy Study of Fabrazyme® Replacement Therapy in Patients With Cardiac Fabry Disease

NCT00140621

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Fujita Health University Hospital Aichi, Japan
  • Sapporo Medical University Hospital Hokkaido, Japan
  • Akune Citizen Hospital Kagoshima, Japan
  • Tohoku University Hospital Miyagi, Japan
View Trial Details
Completed

Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease

NCT00364858

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University Research Foundation for Lysosomal Storage Disease, Inc. Coral Springs, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Children's Memorial Hospital Chicago, Illinois, United States
View all 26 locations
View Trial Details
Completed

A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

NCT00196716

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • II. interní klinika 1. LF UK Prague, Czechia
  • Tartu University Clinics, Department of Internal Medicine Tartu, Estonia
  • Klinika Chorob Metabolicznych, Instytut "Pomnik-Centrum Zdrowia Dziecka" Warsaw, Poland
  • Detská fakultná nemocnica Kramáre I. Interná klinika Bratislava, Slovakia
View Trial Details
Completed

A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

NCT00081497

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of San Francisco San Francisco, California, United States
  • University of Connecticut Health Partners West Hartford, Connecticut, United States
View all 25 locations
View Trial Details
Completed

A Study of Fabrazyme in Pediatric Patients With Fabry Disease

NCT00074958

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • Hopital Edouard Herriot Lyon, France
  • Hopital de la Timone Enfants Marseille, France
  • Hopital Europeen Georges Pompidou Paris, France
View Trial Details

Related conditions